🟢 Revvity is trading 4.68% up today after stronger diagnostics growth and backlog commentary

Revvity is trading at $146.75, up +4.68% following management’s healthcare-conference commentary on stronger diagnostics growth.

• Management also highlighted improving instrument demand and a multi-year-high backlog.
• Revvity emphasized AI-driven laboratory demand and raised full-year diagnostics growth guidance to the high-single-digit range.
• Shares are extending the September 15 advance, when they gained 9.11%, amid broader healthcare-sector strength; no separate September 16 announcement was identified.